AChE/BuChE-IN-7
AChE/BuChE-IN-7 is a dual-action inhibitor with an IC50 valueof 0.15 μM for AChE and 0.7 μM for BuChE, SI of 4.7. AChE/BuChE-IN-7 shows anti-oxidant activity and can mitigate H2O2-induced cytotoxicity. AChE/BuChE-IN-7 has genomic stability and prolonged systemic availability. AChE/BuChE-IN-7 can be used for the research of neurological disease, such as Alzheimer's disease.
For research use only. We do not sell to patients.
- Formula: C25H34N2O3
- Molecular Weight:410.55
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
AChE 0.15 μM (IC50) |
BuChE 0.7 μM (IC50) |
In Vitro
AChE/BuChE-IN-7 (Compound D9) (10-80 μM, 24 h) shows low cytotoxicity in HT-22 murine hippocampal neuronal cells, with an IC50 >80 μM[1].
AChE/BuChE-IN-7 (5-20 μM, 4 h before H2O2) exerts significant neuroprotective effects against H2O2-induced oxidative stress injury in HT-22 cells[1].
AChE/BuChE-IN-7 (5-400 μM) exhibits potent DPPH radical scavenging and ferrous ion chelation activity with IC50 values of 46.9 and 15.7 μM[1].
AChE/BuChE-IN-7 (0-200 μM) shows moderate DNA binding affinity and the ability to maintain genomic stability HT-22 cells[1].
AChE/BuChE-IN-7 (0-250 μM) binds to human serum albumin (HSA) via a static quenching mechanism and prolongs the circulation time[1].
AChE/BuChE-IN-7 binds to Alzheimer's disease-related targets with high affinity[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HT-22 murine hippocampal neuronal cells
-
Concentration:10, 20. 40 and 80 μM
-
Incubation Time:24 h
-
Result:Maintained cell viability >80%.
Chemical Information
-
Molecular Weight 410.55
-
Formula C25H34N2O3
-
SMILES
O=C(N1N=C(C)C=C1C)O[C@H](CC2=CC[C@@]3([H])[C@]4([H])CC5)CC[C@]2(C)[C@@]3([H])CC[C@]4(C)C5=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Research Protocol for Neurological Diseases
PINK1/Parkin-mediated mitophagy pathway is a mitochondrial quality-control signaling axis in which mitochondrial depolarization stabilizes PINK1 on damaged mitochondria, activates Parkin recruitment and E3 ubiquitin ligase activity, promotes ubiquitination of outer mitochondrial membrane proteins, recruits selective autophagy adaptors, and drives lysosomal degradation of damaged mitochondria. In neurological disease research, this pathway is experimentally important because neurons, especially dopaminergic neurons, are highly dependent on mitochondrial integrity, and defective mitochondrial turnover can lead to mitochondrial dysfunction, oxidative stress, impaired neuronal survival, α-synuclein accumulation, and neuroinflammatory damage-associated signals. The genetic disease link is strongest in Parkinson’s disease because mutations in PRKN/parkin cause autosomal recessive juvenile parkinsonism, mutations in PINK1 cause hereditary early-onset Parkinson’s disease, and Drosophila studie
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
-
Alzheimer’s Disease Modeling
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by a progressive decline in cognitive functions and loss of specific types of neurons and synapses. Alzheimer's symptoms can be simulated in mice by injecting drugs (such as Aβ) or genetically modified.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)